Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 110 of the 157 sources its claims cite were checked for support.

Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony

Open access
Zhou, Pengjun, Chen, Chunlan, Patil, Sandip, Dong, Shaowei · 2024 · Frontiers in Nutrition

Abstract

The gut microbiota and immune system interaction play a crucial role in maintaining overall health. Probiotics, prebiotics, and postbiotics have emerged as promising therapeutic approaches to positively influence this complex axis and enhance health outcomes. Probiotics, as live bacteria, promote the growth of immune cells, shape immune responses, and maintain gut barrier integrity. They modify the gut microbiota by fostering beneficial bacteria while suppressing harmful ones. Additionally, probiotics interact with the immune system, increasing immune cell activity and anti-inflammatory cytokine production. Prebiotics, as indigestible fibers, selectively nourish beneficial microorganisms in the gut, enhancing gut microbial diversity and activity. This, in turn, improves gut health and boosts immune responses while controlling inflammation through its immunomodulatory properties. Postbiotics, produced during probiotic fermentation, such as short-chain fatty acids and antimicrobial peptides, positively impact gut health and modulate immune responses. Ensuring quality control and standardization will be essential for successful clinical implementation of these interventions. Overall, understanding and harnessing the gut microbiota-immune system interplay offer promising avenues for improving digestive and immunological health.

Overview

CoChat Summary

## TL;DR

This paper is a narrative review arguing that probiotics, prebiotics, and postbiotics can beneficially modulate the gut microbiota–immune axis and may help in digestive, immune, metabolic, and mental health contexts. It emphasizes mechanistic pathways and the need for quality control, standardization, and personalization before broad clinical use.

## Key findings

  • Probiotics are described as influencing innate and adaptive immunity by increasing cytokines such as IL-12 and IFN-γ, promoting Tregs and IgA production, reducing inflammatory cytokines like TNF-α and IL-6, and supporting gut barrier integrity.
  • Prebiotics are described as selectively feeding beneficial microbes such as Bifidobacteria and Lactobacilli; their fermentation produces SCFAs (acetate, propionate, butyrate), which support colonocyte energy needs, gut barrier function, and anti-inflammatory immune effects.
  • Postbiotics are described as bioactive metabolites from probiotic activity, including SCFAs, bacteriocins, EPS, organic acids, and peptidoglycans; the paper says they can improve intestinal permeability, inhibit pathogenic microbes, and modulate cytokines and Tregs.
  • The paper states clinical promise across several conditions, including IBS, IBD, infectious diarrhea, obesity/metabolic abnormalities, type 2 diabetes, allergies, autoimmune diseases, and mental health issues such as depression and anxiety; however, it does not report original trial effect sizes or pooled estimates.

## Methods

  • Narrative review / conceptual synthesis of the literature on probiotics, prebiotics, postbiotics, the gut microbiota, immunity, and the gut-brain axis.
  • No original study sample, cohort, experiment, or dataset is stated in the paper.
  • The analysis is qualitative, organizing prior findings by mechanism and clinical application rather than using a formal quantitative meta-analysis.

## Limitations

  • The paper itself states that individual variability, safety, efficacy, cost-effectiveness, quality control, standardization, regulation, accessibility, and long-term effects need careful consideration.
  • It also states that more research and well-planned clinical trials are required to fully understand mechanisms and improve therapeutic use.
  • Evident from the text: because this is a narrative review, it does not provide new empirical data, effect sizes, or a formal risk-of-bias assessment.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fnut.2024.1355542

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Interplay between gut microbiota and the immune system: regulation and implications.
Figure 1 Interplay between gut microbiota and the immune system: regulation and implications.CC BY · PubMed Central
Figure 2 Immune system’s impact on gut metabolism: regulation and significance.
Figure 2 Immune system’s impact on gut metabolism: regulation and significance.CC BY · PubMed Central
Figure 3 Microbiota in clinical practice: implications and applications.
Figure 3 Microbiota in clinical practice: implications and applications.CC BY · PubMed Central

Verification

Claims the paper makes

42 Valid · 35 Not valid · 6 Not checked · 55 Own results and interpretations

55 more claims · 18 with their cited sources checked

Create a free account to see all 138 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 55
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 33

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 54 references

Cited by

See all 193

Metadata

Authors
Zhou, P., Chen, C., Patil, S., & Dong, S.
Affiliations
  • Guangdong Pharmaceutical University (CN)
  • Shenzhen Children's Hospital (CN)
Corresponding author
Dong, Shaowei
Venue
Frontiers in Nutrition
Published
2024-02-08
Volume
11
Pages
1355542-1355542
ISSN
2296-861X (ISSN-L)
OpenAlex
W4391648685
Cited by
193
References
54
Citations by year
2026: 55 · 2025: 99 · 2024: 39
FWCI
7.14
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Nutrition (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Keywords
probiotics, prebiotics, postbiotics, gut microbiota, gut-immune axis, immunomodulation, anti-inflammatory cytokines, intestinal barrier integrity, short-chain fatty acids, antimicrobial peptides, microbial diversity, inflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony. https://app.cochat.ai/papers/10.3389/fnut.2024.1355542
The paper
Zhou, P., Chen, C., Patil, S., & Dong, S. (2024). Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2024.1355542

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.